54004-7 |
Human upstream binding factor Ab |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
Human upstream binding factor Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
Titer |
NOR-90 antibody 1:160. |
|
|
|
|
|
SERO |
|
54004-7 |
|
IF |
|
|
Both |
|
|
|
0 |
hUBF Ab Titr Ser IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Bind; Dilution factor; Dilution Factor (Titer); FA; Fac; Fact; Fluorescent antibody; Fluoresent; hUBF; Human upstream binding transcription factor; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; NOR 90; NOR90; NOR-90; Nucleolus organizer regions; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; UBTF |
2.75 |
2.26 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
54005-4 |
Nuclear Ab pattern.nuclear membrane pores |
PrThr |
Ser |
Pt |
Ord |
IF |
|
ACTIVE |
Nuclear membrane pores nuclear Ab pattern [Presence] in Serum by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
Nuclear pores positive. |
|
|
|
|
|
SERO |
|
54005-4 |
|
IF |
|
|
Observation |
|
|
|
0 |
ANA nuclear membrane pores Ser Ql IF |
|
|
|
N |
|
ACIF; ANA; ANA nuclear membrane pores; ANA Pat; ANF; Anticomplement Immunofluorescence; Antinuclear antibody; FA; FANA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF |
2.73 |
2.26 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
54006-2 |
Nuclear Ab pattern.nuclear membrane pores |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
Nuclear membrane pores nuclear Ab pattern [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
Titer |
Nuclear pore antibodies 1:320. |
|
|
|
|
|
SERO |
|
54006-2 |
|
IF |
|
|
Observation |
|
|
|
0 |
ANA nuclear membrane pores Titr Ser IF |
|
|
|
N |
|
ACIF; ANA; ANA nuclear membrane pores; ANA Pat; ANF; Anticomplement Immunofluorescence; Antinuclear antibody; Dilution factor; Dilution Factor (Titer); FA; FANA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; NA; Nuc; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.26 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
54007-0 |
Golgi apparatus Ab |
PrThr |
Ser |
Pt |
Ord |
IF |
|
ACTIVE |
Golgi apparatus Ab [Presence] in Serum by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
Golgi antiobodies pos. |
|
|
|
|
|
SERO |
|
54007-0 |
|
IF |
|
|
Both |
|
|
|
0 |
Golgi apparatus Ab Ser Ql IF |
|
|
|
N |
|
ABS; Aby; ACIF; AGA; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF |
2.56 |
2.26 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
54008-8 |
Golgi apparatus Ab |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
Golgi apparatus Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
Titer |
Golgi antibodies 1:320. |
|
|
|
|
|
SERO |
|
54008-8 |
|
IF |
|
|
Both |
|
|
|
0 |
Golgi apparatus Ab Titr Ser IF |
|
|
|
N |
|
ABS; Aby; ACIF; AGA; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.26 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
54009-6 |
Lysosome Ab |
PrThr |
Ser |
Pt |
Ord |
IF |
|
ACTIVE |
Lysosome Ab [Presence] in Serum by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
Lysosomal antibodies pos. |
|
|
|
|
|
SERO |
|
54009-6 |
|
IF |
|
|
Both |
|
|
|
0 |
Lysosome Ab Ser Ql IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Lysosomal antibody; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF |
2.56 |
2.26 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
5401-5 |
Varicella zoster virus Ab |
Titr |
Ser |
Pt |
SemiQn |
Comp fix |
|
ACTIVE |
Varicella zoster virus Ab [Titer] in Serum by Complement fixation |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
5401-5 |
|
Comp fix |
|
|
Both |
|
|
|
0 |
VZV Ab Titr Ser CF |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CF; Chicken pox; Chicken pox virus; Chickenpox; Comp fixation; Compfix; Complement fixation; Dilution factor; Dilution Factor (Titer); Herpes zoster; HHV-3; Human herpesvirus 3; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; Shingles; SmQn; SR; Titer; Titered; Titre; Ttr; VZ; VZV; Zoster |
2.75 |
1 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
54010-4 |
Lysosome Ab |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
Lysosome Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
Titer |
Lysosomal antibodies 1:160. |
|
|
|
|
|
SERO |
|
54010-4 |
|
IF |
|
|
Both |
|
|
|
0 |
Lysosome Ab Titr Ser IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Lysosomal antibody; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.26 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
54011-2 |
Vimentin Ab |
PrThr |
Ser |
Pt |
Ord |
IF |
|
ACTIVE |
Vimentin Ab [Presence] in Serum by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
54011-2 |
|
IF |
|
|
Both |
|
|
|
0 |
Vimentin Ab Ser Ql IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF; Tumor marker |
2.56 |
2.26 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
54012-0 |
Vimentin Ab |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
Vimentin Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
Vimentin antibodiy 1:640. |
|
|
|
|
|
SERO |
|
54012-0 |
|
IF |
|
|
Both |
|
|
|
0 |
Vimentin Ab Titr Ser IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; Tumor marker |
2.75 |
2.26 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
54013-8 |
Vinculin Ab |
PrThr |
Ser |
Pt |
Ord |
IF |
|
ACTIVE |
Vinculin Ab [Presence] in Serum by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
Vinculin antibodies pos. |
|
|
|
|
|
SERO |
|
54013-8 |
|
IF |
|
|
Both |
|
|
|
0 |
Vinculin Ab Ser Ql IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF; VCL |
2.56 |
2.26 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
54014-6 |
Vinculin Ab |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
Vinculin Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
Vinculin antibodiy 1:160. |
|
|
|
|
|
SERO |
|
54014-6 |
|
IF |
|
|
Both |
|
|
|
0 |
Vinculin Ab Titr Ser IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; VCL |
2.75 |
2.26 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
54015-3 |
Azurocidin Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Azurocidin Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
Azurocidin antibody: positive. |
|
|
|
|
|
SERO |
|
54015-3 |
|
|
|
|
Both |
|
|
|
0 |
Azurocidin Ab Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; AZ; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR |
2.56 |
2.26 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
54016-1 |
Cathepsin G Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Cathepsin G Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
Cathepsin G AB: positive. |
|
|
|
|
|
SERO |
|
54016-1 |
|
|
|
|
Both |
|
|
|
0 |
Cathepsin G Ab Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR |
2.56 |
2.26 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
54017-9 |
Elastase Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Elastase Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
Elastase AB: pos. |
|
|
|
|
|
SERO |
|
54017-9 |
|
|
|
|
Both |
|
|
|
0 |
Elastase Ab Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ELA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR |
2.56 |
2.26 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
54018-7 |
Lactoferrin Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Lactoferrin Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
Lactoferrin AB: pos. |
|
|
|
|
|
SERO |
|
54018-7 |
|
|
|
|
Both |
|
|
|
0 |
Lactoferrin Ab Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Lf; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR |
2.56 |
2.26 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
54019-5 |
Lysozyme Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Lysozyme Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
Lysozyme AB: pos. |
|
|
|
|
|
SERO |
|
54019-5 |
|
|
|
|
Both |
|
|
|
0 |
Lysozyme Ab Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; k208; Lysozymes; Muramidase; N-Acetylmuramide Glycanhydrolase; nGal d 4 Lysozyme, Egg; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rk208; Screen; Serology; Serum; SR |
2.56 |
2.26 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
5402-3 |
Varicella zoster virus Ab |
Titr |
Ser |
Pt |
SemiQn |
LA |
|
ACTIVE |
Varicella zoster virus Ab [Titer] in Serum by Latex agglutination |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
5402-3 |
|
LA |
|
|
Both |
|
|
|
0 |
VZV Ab Titr Ser LA |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chicken pox; Chicken pox virus; Chickenpox; Dilution factor; Dilution Factor (Titer); Herpes zoster; HHV-3; Human herpesvirus 3; ID; Infectious Disease; InfectiousDisease; LAT; Latex agglutination; Microbiology; Point in time; Random; Serum; Shingles; SmQn; SR; Titer; Titered; Titre; Ttr; VZ; VZV; Zoster |
2.75 |
1 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
54020-3 |
Actin.filamentous Ab |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
Actin.filamentous Ab [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
F-actin AB: positive. |
|
|
|
|
|
SERO |
|
54020-3 |
|
|
|
|
Both |
|
|
|
0 |
F-actin Ab SerPl Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; F-actin; Filament; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.26 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
54021-1 |
Actin.filamentous Ab |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Actin.filamentous Ab [Units/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
arb U/mL |
F-actin AB: 140 U/ml. |
|
|
|
|
|
SERO |
|
54021-1 |
|
|
|
|
Both |
|
|
|
0 |
F-actin Ab SerPl-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; F-actin; Filament; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.7 |
2.26 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
54022-9 |
Mutated citrullinated vimentin Ab |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Mutated citrullinated vimentin Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
arb U/mL |
|
|
|
|
|
|
SERO |
|
54022-9 |
|
|
|
|
Both |
|
|
|
0 |
Mut cit vimentin Ab Ser-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; MCV; Mut cit vimentin; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; Tumor marker |
2.7 |
2.26 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
54023-7 |
U1 small nuclear ribonucleoprotein C Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
RNP-C antibody: pos. |
|
|
|
|
|
SERO |
|
54023-7 |
|
|
|
|
Both |
|
|
|
0 |
U1 snRNP-C Ab Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Mixed connective tissue disorder; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Raynaud's Disease; Rh Blood Group System; Ribonuclear protein; RNP; Screen; Serology; Serum; snRNP; snRPC; SR; Systemic lupus erythematosus; U1 RNP; U1 snRNP; U1 snRNP-C; U1RNP |
2.56 |
2.26 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
54024-5 |
sp100 Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
sp100 Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
sp100 antibody positive. |
|
|
|
|
|
SERO |
|
54024-5 |
|
|
|
|
Both |
|
|
|
0 |
sp100 Ab Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Hepatology; Liver; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR |
2.56 |
2.26 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
54025-2 |
Nuclear pore protein gp210 Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Nuclear pore protein gp210 Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
gp210 antibody positive. |
|
|
|
|
|
SERO |
|
54025-2 |
|
|
|
|
Both |
|
|
|
0 |
Nuclear pore prot gp210 Ab Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Nuc; Nuclear pore glycoprotein-210; Nuclear pore prot gp210; Nucleoporin 210kDa; NUP210; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR |
2.69 |
2.26 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
54026-0 |
Soluble liver Ab |
ACnc |
Ser |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Soluble liver Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
U/ml |
SLA/LP antibodies 30 U/ml. |
|
|
|
|
|
SERO |
|
54026-0 |
|
|
|
|
Both |
|
|
|
0 |
Deprecated Soluble liver Ab Ser-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cytokeratin; Hepatology; Liver; Liver-pancreas antigen; O-phosphoseryl-tRNA(Sec) selenium transferase; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SLA; Soluble liver antigen; SR |
2.7 |
2.26 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |